Halozyme To Report Third Quarter 2023 Financial and Operating Results
Go back to Halozyme To Report Third Quarter 2023 Financial and Operating Results| Halozyme Therapeutics, Inc. (NASDAQ: HALO) | Delayed: 81.93 +1.09 (1.35%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $80.84 | 52 Week High | $18.39 | |||
| Open | $81.35 | 52 Week Low | $6.96 | |||
| Day High | $82.99 | P/E | N/A | |||
| Day Low | $80.93 | EPS | $-0.58 | |||
| Volume | 1,660,910 | |||||
